World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
100
Citations
69884
World Ranking
712
National Ranking
43

Medicine

D-Index
101
Citations
70109
World Ranking
7782
National Ranking
440

Overview

Ugur Sahin is affiliated with Johannes Gutenberg University of Mainz in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields such as Infectious Diseases, Molecular Biology, Immunology, Oncology, and Radiology, Nuclear Medicine and Imaging.

The topics covered by their work include:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • RNA Interference and Gene Delivery
  • Monoclonal and Polyclonal Antibodies Research
  • Animal Virus Infections Studies

Among recent significant publications associated with Ugur Sahin are:

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, 2020, New England Journal of Medicine
  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates, 2020, New England Journal of Medicine
  • COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses, 2020, Nature
  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, 2020, Nature
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer, 2023, Nature

Their work has been published extensively in various venues, with the most frequent publication outlets including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Nature
  • Annals of Oncology

Collaborations have been a notable element of their research, with frequent coauthors including:

  • Özlem Türeci
  • Alexander Muik
  • Kena A. Swanson
  • David Cooper
  • Nicholas Kitchin

Best Publications

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Fernando P. Polack;Stephen J. Thomas;Nicholas Kitchin;Judith Absalon

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

    Ugur Sahin;Evelyna Derhovanessian;Matthias Miller;Björn-Philipp Kloke

  • mRNA-based therapeutics — developing a new class of drugs

    Ugur Sahin;Katalin Karikó;Özlem Türeci

  • COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses.

    Ugur Sahin;Alexander Muik;Evelyna Derhovanessian;Isabel Vogler

  • Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

    Lena M. Kranz;Mustafa Diken;Heinrich Haas;Sebastian Kreiter

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

    Yao-Tseng Chen;Matthew J. Scanlan;Ugur Sahin;Özlem Türeci

  • Human neoplasms elicit multiple specific immune responses in the autologous host.

    Ugur Sahin;Ozlem Tureci;Holger Schmitt;Bjorn Cochlovius

  • Mutant MHC class II epitopes drive therapeutic immune responses to cancer

    Sebastian Kreiter;Mathias Vormehr;Niels van de Roemer;Mustafa Diken

  • Personalized vaccines for cancer immunotherapy.

    Ugur Sahin;Özlem Türeci

  • Exploiting the mutanome for tumor vaccination

    John C. Castle;Sebastian Kreiter;Jan Diekmann;Martin Löwer

  • An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.

    Ugur Sahin;Petra Oehm;Evelyna Derhovanessian;Robert A. Jabulowsky

  • Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

    Tiziana Sturniolo;Elisa Bono;Jiayi Ding;Laura Raddrizzani

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

    Robert W Frenck;Nicola P Klein;Nicholas Kitchin;Alejandra Gurtman

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.

    Stephen J. Thomas;Edson D. Moreira;Nicholas Kitchin;Judith Absalon

  • A vaccine targeting mutant IDH1 induces antitumour immunity

    Theresa Schumacher;Lukas Bunse;Stefan Pusch;Felix Sahm

  • BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

    Ugur Sahin;Alexander Muik;Isabel Vogler;Evelyna Derhovanessian

  • Modification of antigen encoding RNA increases stability, translational efficacy and T-cell stimulatory capacity of dendritic cells

    Silke Holtkamp;Sebastian Kreiter;Abderraouf Selmi;Petra Simon

Frequent Co-Authors

Özlem Türeci
Özlem Türeci BioNTech (Germany)
Michael Pfreundschuh
Michael Pfreundschuh Saarland University
John C. Castle
John C. Castle Monte Rosa Therapeutics
Andreas Kuhn
Andreas Kuhn University of Hohenheim
Christoph Huber
Christoph Huber BioNTech (Germany)
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Paul W. H. I. Parren
Paul W. H. I. Parren Leiden University Medical Center
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center
Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can broaden career opportunities. Many students consider pursuing advanced nursing roles, and one popular option is accelerated nurse practitioner programs. These programs offer a fast track to becoming a nurse practitioner, combining intensive coursework with clinical practice.

Individuals without a nursing background can also enter the nursing field through online bsn programs for non nurses. These programs accommodate students coming from diverse academic disciplines and provide foundational knowledge necessary for registered nursing careers.

If you’re seeking accessible entry points into nursing, it’s helpful to research the easiest absn to get into. Accelerated Bachelor of Science in Nursing programs can vary in competitiveness and admission requirements, so targeting accessible options can streamline your path.

Similarly, aspiring practical nurses may explore the easiest lpn programs to get into. Licensed Practical Nurse programs prepare students for essential nursing roles and can serve as a stepping stone toward more advanced positions in healthcare.

Each of these pathways complements studies in Immunology by reinforcing clinical skills and understanding of human health, offering versatile career prospects in the medical and research sectors.

Best Scientists Citing Ugur Sahin

Trending Scientists

Recently Published Articles